Mettler-Toledo International Inc. (MTD) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Mettler-Toledo International Inc. (MTD) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Fiscal Year: January - December
Mettler-Toledo International Inc. (MTD), listed on the NYSE, has a market capitalization of $. As of Dec 07, 2025, the stock is trading at $1,414.86 per share, offering investors a clear view of its current market value. Mettler-Toledo International Inc. is a prominent player in the industry sector, attracting both institutional and retail investors due to its performance and potential.
With a P/E ratio of 35.28, investors can assess the stock's valuation in comparison to its earnings. A P/E ratio is a crucial indicator for value investors, showing whether the stock is over or undervalued relative to its current earnings. Mettler-Toledo International Inc. also offers a dividend yield of N/A , making it an attractive option for income-focused investors who seek regular dividends.
Our Discounted Cash Flow (DCF) analysis reveals that Mettler-Toledo International Inc. (MTD) may be overvalued compared to its intrinsic worth. However, to see the exact DCF fair value, please Login or Upgrade for access.
The proprietary SS Score for Mettler-Toledo International Inc. is a unique metric that analyzes the company's financial health and growth potential. The score takes into account critical factors such as revenue growth, net income, free cash flow (FCF) compound annual growth rate (CAGR), the trend of shares outstanding, and the debt-to-FCF ratio. This helps investors to make a more informed decision, as an undervalued stock might still have poor financial fundamentals.
To view the detailed SS Score for Mettler-Toledo International Inc., Login or Upgrade for access.
The Price to Free Cash Flow (P/FCF) ratio for Mettler-Toledo International Inc. is 32.49, offering insights into how much investors are paying for the company's free cash flow. A lower P/FCF ratio typically suggests that the stock is undervalued, while a higher ratio may indicate overvaluation.
In summary, Mettler-Toledo International Inc. (MTD) has shown consistent financial performance, as illustrated by the financial charts above, which track its revenue growth, net income, free cash flow, and shares outstanding over the past several years. These metrics provide investors with key insights into the company's past and projected future performance. Investors should use the SS Score alongside the DCF Fair Value to make better-informed decisions about whether to buy or hold the stock.
*This analysis is for informational purposes only and does not constitute investment advice. Always read the company's 10-K filings and do your own research before making any investment decisions.
Whether Mettler-Toledo International Inc. (MTD) is a good stock to buy depends on various factors, including its financial health, market conditions, and your investment strategy. Our analysis indicates that the stock may be overvalued compared to its intrinsic value. However, it is important to assess the SS Score and review the company's fundamentals before making any investment decisions.
The fair value of Mettler-Toledo International Inc. (MTD) is determined through our Discounted Cash Flow (DCF) analysis. This value represents the intrinsic worth of the stock based on its expected future cash flows. To view the specific fair value, consider subscribing to our service for complete access.
The SS Score is a proprietary financial quality metric that assesses factors such as revenue growth, net income, free cash flow growth, and debt levels. It helps investors evaluate the overall financial health of Mettler-Toledo International Inc.. To access the full SS Score, consider upgrading your subscription.
Mettler-Toledo International Inc. is a significant player in the industry sector, with a market capitalization of $ and a competitive P/E ratio of 35.28. Investors should compare these metrics with industry peers to gauge whether Mettler-Toledo International Inc. is outperforming or underperforming within its sector.
Mettler-Toledo International Inc. (MTD) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Mettler-Toledo International Inc. (MTD) Presents at Evercore 8th Annual Healthcare Conference Transcript
Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's 'Halftime Report' to explain why he's spotlighting Health Care in his "best stocks in the market." The Committee debates their health care s...
On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying Mettler-Toledo International Inc. (NYSE: MTD). “You've got a good one there,” he added.
COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) today announced it will present at the 8th Annual Evercore Healthcare Conference on Tuesday, December 2 at 9:10 a.m. EST,...
Mettler-Toledo International Inc. ( MTD) Q3 2025 Earnings Call November 7, 2025 8:30 AM EST Company Participants Adam Uhlman - Head of Investor Relations Patrick Kaltenbach - President & CEO Shawn Va...
COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) today announced third quarter results for 2025. Provided below are the highlights: Reported sales increased 8% compared w...
COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) announced it will release its third quarter 2025 financial results after the market close on Thursday, November 6, 2025. ...
COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) announced today that Pablo Perversi has been appointed to its Board of Directors, effective November 6, 2025. Mr. Pervers...
I maintain a buy rating on Mettler-Toledo, highlighting its capital-light, high-cash-generating model and dominant market position. Recent tariff surprises are non-issue; their impact is marginal and ...
Mettler-Toledo (MTD) Q2 EPS Jumps 5%
Mettler-Toledo International Inc. (NYSE:MTD) Q2 2025 Earnings Conference Call August 1, 2025 8:30 AM ET Company Participants Adam William Uhlman - Head of Investor Relations Patrick K. Kaltenbach - P...
Mettler-Toledo International raised its profit forecast for the year on Thursday, after posting better-than-expected second-quarter results, driven by strong demand for its laboratory instruments used...
COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) today announced second quarter results for 2025. Provided below are the highlights: Reported sales increased 4% compared ...
COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) announced it will release its second quarter 2025 financial results after the market close on Thursday, July 31, 2025. Th...
Mettler-Toledo International Inc. boasts exceptional capital efficiency, delivering high returns on invested capital with minimal reinvestment needs, similar to Buffett's See's Candy. The company's st...
MTD moves up over 20 points on a flat day for the broad market
Mettler-Toledo International Inc. (MTD) Q1 2025 Earnings Conference Call Transcript
COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) today announced first quarter results for 2025. Provided below are the highlights: Reported sales declined 5% compared wi...
COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE:MTD) today announced it will present at the BofA Securities 2025 Healthcare Conference on Wednesday, May 14, 2025, at 4:20pm Pa...
Mettler-Toledo has a strong moat with high gross margins (60%) and operating margins (30%), driven by dominant positions in laboratory and industrial scales. The company's valuation has become more at...
COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) announced it will release its first quarter 2025 financial results after the market close on Thursday, May 1, 2025. The C...
Mettler-Toledo International Inc. (NYSE:MTD) Q4 2024 Earnings Conference Call February 7, 2025 8:30 AM ET Company Participants Adam Uhlman - Head of IR Patrick Kaltenbach - CEO Shawn Vadala - CFO Con...
Medical equipment maker Mettler-Toledo International forecast annual profit above estimates on Thursday, banking on strong demand for its laboratory instruments used in drug development.
COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) today announced fourth quarter results for 2024. Provided below are the highlights: Reported and local currency sales inc...
Below estimates were sourced from SimplyWallSt and are intended for educational purposes only as a baseline for the analysis.
| Year | FCF Estimate | % | # Analysts |
|---|---|---|---|
| 2025 | 889.22M | 2.87% | Est @2.9% |
| 2026 | 914.00M | 2.79% | Analyst x1 |
| 2027 | 928.77M | 1.62% | Est @1.6% |
| 2028 | 946.53M | 1.91% | Est @1.9% |
| 2029 | 966.59M | 2.12% | Est @2.1% |
| 2030 | 987.18M | 2.13% | Est @2.1% |
| 2031 | 1,009.10M | 2.22% | Est @2.2% |
| 2032 | 1,032.18M | 2.29% | Est @2.3% |
| 2033 | 1,056.26M | 2.33% | Est @2.3% |
| 2034 | 1,079.62M | 2.21% | Est @2.2% |
Below are the FCF estimates with the discount factor and the calculated present value with the terminal value that led the results above.
| Year | FCF | Discount Factor | PV of Future FCF |
|---|---|---|---|
| 2023A | 860.55M | 1.00 | 860.55M |
| 2024A | 864.45M | 1.00 | 864.45M |
| 2025E | 889.22M | 1.10 | 809.66M |
| 2026E | 914.00M | 1.21 | 757.76M |
| 2027E | 928.77M | 1.32 | 701.11M |
| 2028E | 946.53M | 1.45 | 650.58M |
| 2029E | 966.59M | 1.60 | 604.93M |
| 2030E | 987.18M | 1.75 | 562.54M |
| 2031E | 1.01B | 1.93 | 523.58M |
| 2032E | 1.03B | 2.12 | 487.64M |
| 2033E | 1.06B | 2.32 | 454.36M |
| 2034E | 1.08B | 2.55 | 422.86M |
| Terminal | 15.10B | 2.55 | 5.92B |
The information given by Studying Stocks and provided in the web and/or mobile applications (Platforms) is only factual information and should not be considered financial advice.
Any information contained in this website has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
When creating an account, you acknowledge that you are:
We retain the right to cancel your account for any reason, or refuse your account creation request.
The information on our Platforms is not comprehensive and is intended to provide a summary of the subject matter covered. While we use all reasonable attempts to ensure the accuracy and completeness of the data and information on our Platforms, to the extent permitted by law, we make no warranty regarding the information on these Platforms. You should monitor any changes to the information contained on these Platforms.
Furthermore we make no commitments in regards to the minimum amount of uptime that our platforms will maintain, although we will make ever reasonable attempt to ensure that the platforms are operational. Therefore, any reference of "latest", "current" and related words about the financial data presented here may not be up to date with the financial markets or represent reality of the information.
We are not liable to you or anyone else if interference with or damage to your computer systems occurs in connection with the use of these Platforms or a linked website. You must take your own precautions to ensure that whatever you select for your use from our Platforms is free of viruses or anything else (such as worms or Trojan horses) that may interfere with or damage the operations of your computer systems.
We may, from time to time and without notice, change or add to the Platforms (including the Terms) or the information, products or services described in it. However, we do not undertake to keep the Platforms updated. We are not liable to you or anyone else if errors occur in the information or the Platforms is not up-to-date.
Our Platforms may contain links to websites operated by third parties. Those links are provided for convenience and may not remain current or be maintained. Unless expressly stated otherwise, we do not endorse and are not responsible for the content on those linked websites and have no control over or rights in those linked websites.
These Platforms are for your personal, non-commercial use only. You may not modify, copy, distribute, transmit, display, perform, reproduce, publish, license, commercially exploit, create derivative works from, transfer, or sell any Content, software, products or services contained within these Platforms. You may not use these Platforms, or any of its Content, to further any commercial purpose, including any advertising or advertising revenue generation activity on your own website.
You must not do any act that we would deem to be inappropriate, is unlawful or is prohibited by any laws applicable to these Platforms, including but not limited to:
If we allow you to post any information to our Platforms, we have the right to take down this information at our sole discretion and without notice.
To the maximum extent permitted by law, we make no warranties or representations about these Platforms or the Content, including but not limited to warranties or representations that they will be complete, accurate or up-to-date, that access will be uninterrupted or error-free or free from viruses, or that these Platforms will be secure.
We reserve the right to restrict, suspend or terminate without notice your access to these Platforms, any Content, or any feature of these Platforms at any time without notice and we will not be responsible for any loss, cost, damage or liability that may arise as a result.
To the maximum extent permitted by law, in no event shall we be liable for any direct and indirect loss, damage or expense – irrespective of the manner in which it occurs – which may be suffered due to your use of our Platforms and/or the information or materials contained on it, or as a result of the inaccessibility of these Platforms and/or the fact that certain information or materials contained on it are incorrect, incomplete or not up-to-date.
This website utilises cookies. If you do not have cookies enabled in your web browser some functions of the site may not work as intended.